Literature DB >> 20302939

Alzheimer's disease and tauopathy studies in flies and worms.

Jill Wentzell1, Doris Kretzschmar.   

Abstract

Progressive dementias like Alzheimer's Disease (AD) and other tauopathies are an increasing threat to human health worldwide. Although significant progress has been made in understanding the pathogenesis of these diseases using cell culture and mouse models, the complexity of these diseases has still prevented a comprehensive understanding of their underlying causes. As with other neurological diseases, invertebrate models have provided novel genetic approaches for investigating the molecular pathways that are affected in tauopathies, including AD. This review focuses on transgenic models that have been established in Drosophila melanogaster and Caenorhabditis elegans to investigate these diseases, and the insights that have been gained from these studies. Also included are a brief description of the endogenous versions of human "disease genes" (like tau and the Amyloid Precursor Protein) that are expressed in invertebrates, and an overview of results that have been obtained from animals lacking or overexpressing these genes. These diverse models can be used to advance our knowledge about how these proteins acquire a pathogenic function and how disrupting their normal functions may contribute to neurological pathologies. They also provide powerful assays for identifying molecular and genetic interactions that are important in developing or preventing the deleterious effects. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20302939      PMCID: PMC2894260          DOI: 10.1016/j.nbd.2010.03.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  92 in total

1.  Genetic modifiers of tauopathy in Drosophila.

Authors:  Joshua M Shulman; Mel B Feany
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

2.  A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster.

Authors:  Alyce Finelli; Anju Kelkar; Ho-Juhn Song; Haidi Yang; Mary Konsolaki
Journal:  Mol Cell Neurosci       Date:  2004-07       Impact factor: 4.314

3.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

4.  Family-based association between Alzheimer's disease and variants in UBQLN1.

Authors:  Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 5.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

6.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.

Authors:  Brian C Kraemer; Bin Zhang; James B Leverenz; James H Thomas; John Q Trojanowski; Gerard D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-18       Impact factor: 11.205

Review 7.  Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

Authors:  Paul R Turner; Kate O'Connor; Warren P Tate; Wickliffe C Abraham
Journal:  Prog Neurobiol       Date:  2003-05       Impact factor: 11.685

8.  Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.

Authors:  Koichi Iijima; Hsin-Ping Liu; Ann-Shyn Chiang; Stephen A Hearn; Mary Konsolaki; Yi Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

9.  In vivo aggregation of beta-amyloid peptide variants.

Authors:  D S Fay; A Fluet; C J Johnson; C D Link
Journal:  J Neurochem       Date:  1998-10       Impact factor: 5.372

10.  Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila.

Authors:  Weihuan Cao; Ho-Juhn Song; Tina Gangi; Anju Kelkar; Isha Antani; Dan Garza; Mary Konsolaki
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

View more
  16 in total

Review 1.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

2.  MSUT2 is a determinant of susceptibility to tau neurotoxicity.

Authors:  Chris R Guthrie; Lynne Greenup; James B Leverenz; Brian C Kraemer
Journal:  Hum Mol Genet       Date:  2011-02-25       Impact factor: 6.150

3.  Mass Histology to Quantify Neurodegeneration in Drosophila.

Authors:  Elizabeth R Sunderhaus; Doris Kretzschmar
Journal:  J Vis Exp       Date:  2016-12-15       Impact factor: 1.355

4.  Glial Draper Rescues Aβ Toxicity in a Drosophila Model of Alzheimer's Disease.

Authors:  Arpita Ray; Sean D Speese; Mary A Logan
Journal:  J Neurosci       Date:  2017-11-06       Impact factor: 6.167

Review 5.  Structural aspects of the aging invertebrate brain.

Authors:  Sandra C Koch; Annie Nelson; Volker Hartenstein
Journal:  Cell Tissue Res       Date:  2021-01-06       Impact factor: 5.249

6.  Modeling Alzheimer's disease: from past to future.

Authors:  Claudia Saraceno; Stefano Musardo; Elena Marcello; Silvia Pelucchi; Monica Di Luca
Journal:  Front Pharmacol       Date:  2013-06-19       Impact factor: 5.810

7.  A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug.

Authors:  Philip F Copenhaver; Thimmappa S Anekonda; Derek Musashe; Kristine M Robinson; Jenna M Ramaker; Tracy L Swanson; Teri L Wadsworth; Doris Kretzschmar; Randall L Woltjer; Joseph F Quinn
Journal:  Dis Model Mech       Date:  2011-05-19       Impact factor: 5.758

8.  Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease.

Authors:  Natalia Crespo-Biel; Clara Theunis; Fred Van Leuven
Journal:  Int J Alzheimers Dis       Date:  2012-06-08

Review 9.  Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products.

Authors:  Mohammad Amjad Kamal; Muneeb U Rehman; Mashoque Ahmad Rather; Andleeb Khan; Saeed Alshahrani; Hina Rashid; Marwa Qadri; Summya Rashid; Rana M Alsaffar
Journal:  Mediators Inflamm       Date:  2021-07-31       Impact factor: 4.711

10.  Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models.

Authors:  Thomas Kramer; Boris Schmidt; Fabio Lo Monte
Journal:  Int J Alzheimers Dis       Date:  2012-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.